These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29444522)

  • 1. Psychotic Symptoms and Attitudes toward Medication Mediate the Effect of Insight on Personal-Social Functions in Patients with Schizophrenia: One-Year Randomized Controlled Trial and Follow-Up.
    Zheng Y; Ning Y; She S; Deng Y; Chen Y; Yi W; Lu X; Chen X; Li J; Li R; Zhang J; Xiao D; Wu H; Wu C
    Psychopathology; 2018; 51(3):167-176. PubMed ID: 29444522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of time and duration of untreated psychosis on cognitive and social functioning in Chinese patients with first-episode schizophrenia: A 1-year study.
    Heeramun-Aubeeluck A; Liu N; Fischer F; Huang N; Chen F; He L; Yang C; Luo Y; Lu Z
    Nord J Psychiatry; 2015 May; 69(4):254-61. PubMed ID: 25731069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.
    Widschwendter CG; Kemmler G; Rettenbacher MA; Yalcin-Siedentopf N; Hofer A
    BMC Psychiatry; 2018 Jun; 18(1):212. PubMed ID: 29954366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive-behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China.
    Li ZJ; Guo ZH; Wang N; Xu ZY; Qu Y; Wang XQ; Sun J; Yan LQ; Ng RM; Turkington D; Kingdon D
    Psychol Med; 2015 Jul; 45(9):1893-905. PubMed ID: 25532460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Community-Based Social Skills Training and Tai-Chi Exercise on Outcomes in Patients with Chronic Schizophrenia: A Randomized, One-Year Study.
    Kang R; Wu Y; Li Z; Jiang J; Gao Q; Yu Y; Gao K; Yan Y; He Y
    Psychopathology; 2016; 49(5):345-355. PubMed ID: 27584836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-stage integrated care versus antipsychotic medication alone on outcomes of schizophrenia: One-year randomized controlled trial and follow-up.
    She S; Deng Y; Chen Y; Wu C; Yi W; Lu X; Chen X; Li J; Li R; Zhang J; Xiao D; Wu H; Ning Y; Zheng Y
    Psychiatry Res; 2017 Aug; 254():164-172. PubMed ID: 28463714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.
    Mohamed S; Rosenheck R; McEvoy J; Swartz M; Stroup S; Lieberman JA
    Schizophr Bull; 2009 Mar; 35(2):336-46. PubMed ID: 18586692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable.
    Gharabawi G; Bossie C; Turkoz I; Kujawa M; Mahmoud R; Simpson G
    J Nerv Ment Dis; 2007 Dec; 195(12):976-82. PubMed ID: 18091190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium nitroprusside treatment for psychotic symptoms and cognitive deficits of schizophrenia: A randomized, double-blind, placebo-controlled trial.
    Wang X; Zhao J; Hu Y; Jiao Z; Lu Y; Ding M; Kou Y; Li B; Meng F; Zhao H; Li H; Li W; Yang Y; Lv L
    Psychiatry Res; 2018 Nov; 269():271-277. PubMed ID: 30170285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Psychoeducation on Long-term Inpatients with Schizophrenia and Schizoaffective Disorder.
    Yanagida N; Uchino T; Uchimura N
    Kurume Med J; 2017 May; 63(3.4):61-67. PubMed ID: 28381728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic treatment of psychotic disorders in forensic psychiatry: Patients' perception of coercion and its predictors.
    Horvath J; Steinert T; Jaeger S
    Int J Law Psychiatry; 2018; 57():113-121. PubMed ID: 29548498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved insight affects social outcomes in involuntarily committed psychotic patients: a longitudinal study in the Netherlands.
    van Baars AW; Wierdsma AI; Hengeveld MW; Mulder CL
    Compr Psychiatry; 2013 Oct; 54(7):873-9. PubMed ID: 23618608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
    J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia.
    Kim SW; Yoon JS; Kim YS; Ahn YM; Kim CE; Go HJ; Chee IS; Jung SW; Chung YC; Kim YD; Joe S; Lee J; Kwon YJ; Yoon BH; Jae YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):228-35. PubMed ID: 22516251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.